Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian B McDermott

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Nature Immunology|February 12, 2019
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responsesMasaru Kanekiyo, M Gordon Joyce, Rebecca A Gillespie, et al.
Nature|April 12, 2019
Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRETMaolin Lu, Xiaochu Ma, Luis R Castillo-Menendez, et al.
Cell Reports|April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer baseAngela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Plos Medicine|January 25, 2018
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adultsMartin R Gaudinski, Emily E Coates, Katherine V Houser, et al.
Scientific Reports|October 26, 2022
Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half lifeBaoshan Zhang, Deepika Gollapudi, Jason Gorman, et al.
The New England Journal of Medicine|November 1, 2022
Safety and Efficacy of a Monoclonal Antibody against Malaria in MaliKassoum Kayentao, Aissata Ongoiba, Anne C Preston, et al.
Immunity|November 10, 2022
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A virusesSyed M Moin, Jeffrey C Boyington, Seyhan Boyoglu-Barnum, et al.
Nature Immunology|April 14, 2019
Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responsesMasaru Kanekiyo, M Gordon Joyce, Rebecca A Gillespie, et al.
Science Translational Medicine|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responsesKristen W Cohen, Stephen C De Rosa, William J Fulp, et al.
Cell Host & Microbe|March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodiesSamantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Nature Immunology|February 12, 2019
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responsesMasaru Kanekiyo, M Gordon Joyce, Rebecca A Gillespie, et al.
Nature|April 12, 2019
Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRETMaolin Lu, Xiaochu Ma, Luis R Castillo-Menendez, et al.
Cell Reports|April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer baseAngela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Plos Medicine|January 25, 2018
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adultsMartin R Gaudinski, Emily E Coates, Katherine V Houser, et al.
Scientific Reports|October 26, 2022
Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half lifeBaoshan Zhang, Deepika Gollapudi, Jason Gorman, et al.
The New England Journal of Medicine|November 1, 2022
Safety and Efficacy of a Monoclonal Antibody against Malaria in MaliKassoum Kayentao, Aissata Ongoiba, Anne C Preston, et al.
Immunity|November 10, 2022
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A virusesSyed M Moin, Jeffrey C Boyington, Seyhan Boyoglu-Barnum, et al.
Nature Immunology|April 14, 2019
Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responsesMasaru Kanekiyo, M Gordon Joyce, Rebecca A Gillespie, et al.
Science Translational Medicine|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responsesKristen W Cohen, Stephen C De Rosa, William J Fulp, et al.
Cell Host & Microbe|March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodiesSamantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
Pageof 18